American Portfolios Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-148
Closed -$24.5K 3581
2021
Q2
$24.5K Buy
148
+5
+3% +$835 ﹤0.01% 2126
2021
Q1
$21.9K Buy
143
+92
+180% +$12.5K ﹤0.01% 2020
2020
Q4
$6.4K Hold
51
﹤0.01% 2309
2020
Q3
$5.17K Sell
51
-5
-9% -$510 ﹤0.01% 2272
2020
Q2
$5.45K Hold
56
﹤0.01% 2204
2020
Q1
$4.65K Hold
56
﹤0.01% 2119
2019
Q4
$6.22K Sell
56
-5
-8% -$514 ﹤0.01% 2195
2019
Q3
$6.05K Buy
61
+26
+74% +$2.58K ﹤0.01% 2124
2019
Q2
$3.47K Buy
35
+22
+169% +$2.1K ﹤0.01% 2305
2019
Q1
$1.43K Hold
13
﹤0.01% 2434
2018
Q4
$1.2K Buy
+13
New +$1.31K ﹤0.01% 2232

Other funds holding PRAH

American Portfolios Advisors's PRAH Position: Q3 2021 in Review

American Portfolios Advisors sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 148 shares — an estimated $24.5K sold.

American Portfolios Advisors first reported a position in PRAH in Q4 2018 and held it in 11 quarters. The position peaked at $24.5K in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • American Portfolios Advisors reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • American Portfolios Advisors sold 148 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $24.5K.
  • American Portfolios Advisors first reported a position in PRA Health Sciences, Inc. in Q4 2018 and held it in 11 quarters.
  • American Portfolios Advisors's PRA Health Sciences, Inc. position peaked at $24.5K in Q2 2021.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on American Portfolios Advisors's 13F filing for Q3 2021, filed 22 Mar 2023.